#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Acute respiratory distress syndrome Malignant fibrous histiocytoma Lymphangiosarcoma Follicular lymphoma stage II Ovarian epithelial cancer Soft tissue sarcoma Pulmonary arterial hypertension Osteopetrosis Hypophosphatasia Hereditary neuropathic amyloidosis Pyruvate kinase deficiency anaemia Peritoneal mesothelioma malignant Plasma cell myeloma refractory Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Treatment Hereditary ataxia – Life with Disease Brain stem glioma – Trials in Disease Sjogren’s syndrome Myelodysplastic syndrome with excess blasts Biotinidase deficiency – Basic Information Alport’s syndrome – Treatment Angiosarcoma non-metastatic – Trials in Disease Nodal marginal zone B-cell lymphoma – Life with Disease Activated PI3 kinase delta syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    STREPTOCOCCUS VIRIDANS Bexmarilimab Sebetralstat Relebactam AZD0120 Telmisartan Idarubicin Hydroxocobalamin Ro7247669 Lna043 Cls12311 Flutemetamol (18F) ALN-961583 Lutetium (177Lu) Oxodotreotide Ripretinib Relatlimab ZAMPILIMAB Axatilimab Cloxacillin Ab-1002 More therapies…

    Learn about Your Condition

    Haemorrhoids Hydrocephalus Dyslipidaemia Glomerulonephritis chronic Spermatocele Neonatal hyperglycaemia Delayed graft function Breast conserving surgery Pelvic venous thrombosis Round cell liposarcoma Arthritis infective Epiphysiolysis Ovarian cancer stage IV Mesothelioma malignant Laryngeal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study of LB-100 and Azenosertib for Patients with Metastatic Colorectal Cancer

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • 3-(4-Methylpiperazine-1-Carbonyl)-7-Oxabiclo[2.2.1]Heptane-2-Carboxylic Acid
    • Azenosertib
    The Netherlands

  • Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    Portugal Spain

  • A Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    France Germany Italy The Netherlands Poland Spain

  • Study of Pembrolizumab and Temozolomide for Patients with Metastatic Colorectal Cancer Who Have Not Responded to Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Pembrolizumab
    • Temozolomide
    Italy

  • Study of Galunisertib and Capecitabine for Patients with Advanced Chemotherapy-Resistant Colorectal Cancer with Peritoneal Metastases

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Galunisertib
    • Capecitabine
    The Netherlands

  • Study on Methadone Hydrochloride and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    • Neoplasm malignant
    Investigated Drugs:
    • Methadone Hydrochloride
    • Fluorouracil
    • Folinic Acid
    Germany
Previous Page
1 … 8 9 10 11 12 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!